SAN DIEGO, March 29, 2023 /PRNewswire/ -- Sorrento Therapeutics, Inc. (SRNEQ) (OTC: SRNEQ, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat ...
Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19. Sorrento's multimodal, ...
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results